Last reviewed · How we verify

NCT05365295: TDAH-DRM

Study of ADHD Children's Sensitivity to Memory Error Production

Completed NA Last updated 19 September 2025
What this trial tests

NA trial testing DRM (Deese, Roediger et McDermott task) in ADHD in 28 participants. Completed in 17 October 2022.

Timeline
28 June 2022
Primary endpoint
17 October 2022
17 October 2022

Quick facts

Lead sponsorUniversity Hospital, Angers
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment28
Start date28 June 2022
Primary completion17 October 2022
Estimated completion17 October 2022
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Angers

Who can join

Adults 8 to 11, any sex, with ADHD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to test whether children with Attention Deficit/Hyperactivity Disorder (ADHD) are more susceptible to false memory production using a DRM paradigm. The number of "critical decoy production" errors will be analyzed and compared to the calibration of the test.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for ADHD

Currently open trials in the same condition.

Other University Hospital, Angers trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05365295.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing